Correspondence

Joint letter from the CMA and the General Pharmaceutical Council: pricing during the COVID-19 pandemic

An open letter to pharmacy owners and superintendent pharmacists.

Documents

Details

Read all of our updates about coronavirus (COVID-19), and how the CMA is responding to the ongoing outbreak on our dedicated COVID-19 response page.

Updates to this page

Published 29 June 2020

Sign up for emails or print this page